Diagnostic Accuracy and Prognostic Relevance of the Measurement of Cardiac Natriuretic Peptides: A Review
Top Cited Papers
- 1 January 2004
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 50 (1) , 33-50
- https://doi.org/10.1373/clinchem.2003.024760
Abstract
Background: The pathophysiologic and clinical relevance of cardiac natriuretic hormone (CNH) assays has been investigated in numerous experimental and clinical studies. Authors have sought to evaluate the diagnostic accuracy and prognostic relevance of the measurement of CNHs according to evidence-based laboratory medicine principles.Methods: In June 2003, we ran a computerized literature search on National Library of Medicine using keywords “ANP” and “BNP” and found more than 12 300 and 1200 articles, respectively. A more refined search with keywords “ANP or BNP assay” extracted ∼7000 and 800 articles, respectively. Only studies specifically designed to evaluate the diagnostic accuracy and prognostic relevance of CNH measurements were selected from this huge mass of articles to be discussed in this review.Content: Several studies suggested that CNH assays may be clinically useful for the screening and classification of patients with heart failure, as a prognostic marker in cardiovascular disease, in the follow-up of patients with heart failure, and because they may reduce the need for further cardiac investigation. However, it is difficult to compare even the best-designed studies because not only did the authors evaluate different populations, they also used different gold standards.Conclusions: CNH assays and conventional diagnostic work-ups provide complementary information for evaluation of the presence and severity of cardiac dysfunction and clinical disease. Several aspects of CNH assays are still to be elucidated, and further work is needed to carefully assess their diagnostic accuracy and prognostic value in cardiac disease.Keywords
This publication has 146 references indexed in Scilit:
- Plasma Brain Natriuretic Peptide Levels and Blood Pressure Tracking in the Framingham Heart StudyHypertension, 2003
- Doppler Echocardiography-Derived Index of Myocardial Performance (TEI Index)Japanese Circulation Journal, 2001
- Effect of Beta-Blocker on Left Ventricular Function and Natrituretic Peptides in Patients With Chronic Heart Failure Treated With Angiotensin-Converting Enzyme InhibitorJapanese Circulation Journal, 2000
- Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1European Heart Journal, 1999
- Pathophysiologic Relevance of Measuring the Plasma Levels of Cardiac Natriuretic Peptide Hormones in HumansHormone and Metabolic Research, 1999
- Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure.Heart, 1996
- Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker.Heart, 1995
- Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.Heart, 1994
- Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplastyAmerican Heart Journal, 1993
- Short-Term Effects of Atenolol and Nifedipine on Atrial Natriuretic Peptide, Plasma Renin Activity, and Plasma Aldosterone in Patients with Essential HypertensionThe Journal of Clinical Pharmacology, 1991